Drug-drug Interaction Study of Digoxin and AT-527 (R07496998)
Clinical trial NCT05137626 · COMPLETED
Trial details
- NCT number
- NCT05137626
- Sponsor
- Atea Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-03
- Primary completion
- 2021-12-12
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.